- Physician's Weekly

Molecular Profiling Improves Outcomes in Biliary Tract Cancer

Mar 14, 2024

Patients with biliary cancer who undergo molecular profiling appear to survive significantly longer when compared with those who do not.

Symptom Assessment Plus Endoscopy Superior in Crohn’s Disease

Mar 13, 2024

American Gastroenterological Association guidelines suggest using symptom assessment and endoscopic evaluation to monitor patients with Crohn’s disease.

Q&A: Improving Obesity Care Through a Machine Learning Framework

Mar 13, 2024

It is imperative that physicians talk to their patients about obesity, make shared treatment decisions, and get patients to the right provider.

Q&A: Chemoradiation With Radiotherapy Improves NSCLC Outcomes

Mar 12, 2024

“This technology gives us the ability to be more precise and personalized to each patient,” says Percy Lee, MD.

Comorbidity Clusters Help Predict COPD Hospitalization & Mortality

Mar 11, 2024

Objective assessment of comorbidities shows potential to improve prognostication and deploy interventions to reduce modifiable risk.

Medication Programs Boost Patient Outcomes & Adherence by 20%

Mar 8, 2024

According to Samuel K. Peasah, PhD, MBA, RPh, “almost half of patients do not take their medications for several reasons, including forgetfulness or cost.”

AI Learning Program Improves Tumor Board Recommendation Concordance to Nearly 70%

Mar 7, 2024

“Precision medicine is rapidly advancing, and keeping up with the deluge of discoveries requires new ways of processing information,” Dr. Gruber advises.

Overcuffing & Undercuffing: Effects of Size on the Accuracy of Blood Pressure Readings

Mar 6, 2024

Using a one-size-fits-all blood pressure cuff for patients with varying arm sizes can result in significantly inaccurate BP readings.

Making the Case for Portable MRI in Assessing MS

Mar 3, 2024

Study results support the use of portable MRI in creating quality imaging for use in assessing patients with MS.

PROFILE Trial: Top-Down Treatment Strategy Benefits Patients With Early Crohn’s Disease

Mar 1, 2024

A top-down treatment strategy resulted in improved outcomes compared with an accelerated step-down treatment strategy in patients with newly diagnosed Crohn’s disease.

Promising Data for JAK Inhibitors in Crohn’s Disease

Mar 1, 2024

Ritlecitinib and brepocitinib were associated with improved efficacy outcomes compared with placebo in patients with moderate to severe Crohn’s disease.

Novel Agent VTX002 Shows Promise for Patients With UC in Phase 2 Study

Mar 1, 2024

Phase 2 trial associates ritlecitinib and brepocitinib with improved outcomes compared with placebo in patients with moderate to severe ulcerative colitis.

Risankizumab Displays Efficacy for Patients With UC

Mar 1, 2024

Results from a phase 2 study associate VTX002 with increased clinical, endoscopic, and histologic remission rates for patients with moderately to severely active ulcerative colitis.

Disparities in Access to Neurological Care for MS

Feb 29, 2024

Study findings underscore the existence of disparities in geographic access to neurologic care for MS.

Functionally Distinct Mechanisms Implicated in MS Risk

Feb 29, 2024

A recent study led by Philip De Jager, MD, PhD, marked a significant milestone in understanding the clinical heterogeneity of MS outcomes.

Addressing Spiritual Questions in the Exam Room

Feb 28, 2024

Although trained to avoid discussing religion, physicians can engage with patients who initiate these conversations. Here’s how to best handle such situations.